Name: UMIN ID:
Unique ID issued by UMIN | UMIN000028130 |
---|---|
Receipt number | R000032203 |
Scientific Title | Special Drug-Use Results Survey of IMBRUVICA Capsules 140 mg (relapsed or refractory mantle cell lymphoma [MCL]) |
Date of disclosure of the study information | 2017/07/07 |
Last modified on | 2023/11/01 20:49:09 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/07/07 16:39:08 | ||
2 | Update | 2017/10/18 09:50:19 | Last name of contact person Last name of contact person TEL TEL Tel1 Email1 |
|
3 | Update | 2019/03/06 11:19:40 | Name of person sending information Name of person sending information |
|
4 | Update | 2023/11/01 20:49:09 | Recruitment status Date of IRB Last follow-up date |